RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Prof. Andrea Laslop, MD, joined the Austrian Federal Office for Safety in Health Care in 2006. Within the business unit Austrian Medicines and Medical Devices Agency she is head of the Scientific Office, which focusses on centralised European procedures during drug development, marketing authorisation and life-cycle management. Since 2003 she is a member of the European Medicines Agency Scientific Advice Working Party and since 2007 of the Committee for Human Medicinal Products. 

Prior to this Andrea Laslop worked as professor of pharmacology and toxicology at the Medical University of Innsbruck, Austria, where she had earned her degree as medical doctor with subsequent specialization in pharmacology and toxicology.